All News

Pharmacy managers and educators offer career advice.

On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.

Insurers, physicians, and others are advising patients with chronic conditions to ensure they have more than enough medication on hand. 

A new study identified demographics that characterize a higher risk of conscientious vaccination exemptions for children in Texas.

Sarilumab is currently used to treat adult patients with moderately-to-severely active rheumatoid arthritis after treatment with at least 1 disease-modifying antirheumatic drug.

President Trump and his health advisors announced a 15-day plan to slow the spread of COVID-19.

Empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) is being investigated to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.

A clinical trial evaluating an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, has been launched, with volunteers receiving the first injection on March 16.

Approximately 1 million individuals are living with multiple sclerosis in the United States, according to the National MS Society.

Walgreens, CVS Health, and Target said they will start providing coronavirus disease (COVID-19) testing in their parking lots.

Walk into a pharmacy in 2030 and there’s a good chance you’ll see a pharmacist. And there’s a good chance the pharmacist will have little or nothing to do with dispensing.

An update on how COVID-19 is affecting pharmacy.

More than one-third of all children in the United States are not following the recommended vaccine schedule, according to a new study.

A new study examines why some individuals are able to fight off the flu better than others. The answer, in part, may lead back to childhood.

Fish oil supplementation may be associated with lower all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events.

The World Health Organization declared the novel coronavirus outbreak a pandemic.

A new study found several shortcomings in blood pressure management.

At the 2020 Conference on Retroviruses and Opportunistic Infections (CROI), longer-term study results on emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets (Descovy, Gilead) for HIV PrEP were presented.

Eleven Schnuck Markets’ pharmacies will close after CVS Pharmacy’s acquisition of 110 Schnuck’s pharmacies.

Nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) has been approved for the treatment of chronic fibrosing interstitial lung disease with a progressive phenotype.

Combating the opioid epidemic is a popular cause, and many organizations, government entities, and health care groups have responded.

The Warren County Health Department informed CVS Health that patients are considered to be at low risk, but is still taking precautions. 

President Donald Trump has signed a bill that will provide more than $8.3 billion to fight the coronavirus disease outbreak.

Strategies for seizing revenue opportunities outside of the PBM.

Plus, ASHP comments on the latest drug shortage.

Advil Dual Action, an ibuprofen and acetaminophen fixed-dose combination, has been approved as an OTC product for pain relief.